Labcorp Holdings Book Value Per Share Growth & History (LH)
Labcorp Holdings's book value per share was $104.86 for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $104.86 | $8.31 | +8.61% |
| 2024 | 2024-12-31 | $96.55 | $2.69 | +2.86% |
| 2023 | 2023-12-31 | $93.86 | -$20.61 | −18.01% |
| 2022 | 2022-12-31 | $114.47 | $4.13 | +3.74% |
| 2021 | 2021-12-31 | $110.35 | $13.56 | +14.01% |
| 2020 | 2020-12-31 | $96.79 | $18.14 | +23.07% |
| 2019 | 2019-12-31 | $78.64 | $7.37 | +10.35% |
| 2018 | 2018-12-31 | $71.27 | $4.49 | +6.73% |
| 2017 | 2017-12-31 | $66.77 | $13.04 | +24.27% |
| 2016 | 2016-12-31 | $53.73 | $4.91 | +10.07% |
| 2015 | 2015-12-31 | $48.82 | $15.48 | +46.42% |
| 2014 | 2014-12-31 | $33.34 | $4.27 | +14.69% |
| 2013 | 2013-12-31 | $29.07 | -$23.82 | −45.04% |
| 2012 | 2012-12-31 | $52.89 | $27.29 | +106.61% |
| 2011 | 2011-12-31 | $25.60 | $1.51 | +6.28% |
| 2010 | 2010-12-31 | $24.08 | $4.08 | +20.42% |
| 2009 | 2009-12-31 | $20.00 | $4.40 | +28.18% |
| 2008 | 2008-12-31 | $15.60 | — | — |
Labcorp Holdings quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $106.39 | $4.18 | +4.09% |
| Q1 2026 | 2026-03-31 | $106.06 | $6.92 | +6.99% |
| Q4 2025 | 2025-12-31 | $104.86 | $8.31 | +8.61% |
| Q3 2025 | 2025-09-30 | $104.78 | $7.17 | +7.34% |
| Q2 2025 | 2025-06-30 | $102.20 | $6.67 | +6.98% |
| Q1 2025 | 2025-03-31 | $99.13 | $4.71 | +4.99% |
| Q4 2024 | 2024-12-31 | $96.55 | $2.69 | +2.86% |
| Q3 2024 | 2024-09-30 | $97.61 | $4.88 | +5.26% |
| Q2 2024 | 2024-06-30 | $95.53 | -$3.51 | −3.54% |
| Q1 2024 | 2024-03-31 | $94.42 | -$4.73 | −4.77% |
| Q4 2023 | 2023-12-31 | $93.86 | -$20.61 | −18.01% |
| Q3 2023 | 2023-09-30 | $92.73 | -$19.90 | −17.67% |
| Q2 2023 | 2023-06-30 | $99.04 | -$15.25 | −13.34% |
| Q1 2023 | 2023-03-31 | $99.15 | -$12.76 | −11.40% |
| Q4 2022 | 2022-12-31 | $114.47 | $4.13 | +3.74% |
| Q3 2022 | 2022-09-30 | $112.64 | $1.97 | +1.78% |
| Q2 2022 | 2022-06-30 | $114.29 | $7.55 | +7.07% |
| Q1 2022 | 2022-03-31 | $111.91 | $9.44 | +9.21% |
| Q4 2021 | 2021-12-31 | $110.35 | $13.56 | +14.01% |
| Q3 2021 | 2021-09-30 | $110.66 | $26.07 | +30.82% |
| Q2 2021 | 2021-06-30 | $106.74 | $31.18 | +41.25% |
| Q1 2021 | 2021-03-31 | $102.47 | $30.17 | +41.73% |
| Q4 2020 | 2020-12-31 | $96.79 | $18.14 | +23.07% |
| Q3 2020 | 2020-09-30 | $84.59 | $10.35 | +13.94% |
| Q2 2020 | 2020-06-30 | $75.57 | $2.52 | +3.44% |
| Q1 2020 | 2020-03-31 | $72.30 | $0.25 | +0.34% |
| Q4 2019 | 2019-12-31 | $78.64 | $7.37 | +10.35% |
| Q3 2019 | 2019-09-30 | $74.24 | $2.76 | +3.86% |
| Q2 2019 | 2019-06-30 | $73.05 | $4.05 | +5.88% |
| Q1 2019 | 2019-03-31 | $72.05 | $3.65 | +5.33% |
| Q4 2018 | 2018-12-31 | $71.27 | $4.49 | +6.73% |
| Q3 2018 | 2018-09-30 | $71.48 | $11.55 | +19.28% |
| Q2 2018 | 2018-06-30 | $69.00 | $11.38 | +19.75% |
| Q1 2018 | 2018-03-31 | $68.40 | $13.30 | +24.15% |
| Q4 2017 | 2017-12-31 | $66.77 | $13.04 | +24.27% |
| Q3 2017 | 2017-09-30 | $59.93 | $5.41 | +9.92% |
| Q2 2017 | 2017-06-30 | $57.62 | $5.63 | +10.83% |
| Q1 2017 | 2017-03-31 | $55.10 | $4.50 | +8.89% |
| Q4 2016 | 2016-12-31 | $53.73 | $4.91 | +10.07% |
| Q3 2016 | 2016-09-30 | $54.52 | $7.02 | +14.77% |
| Q2 2016 | 2016-06-30 | $51.99 | $4.70 | +9.95% |
| Q1 2016 | 2016-03-31 | $50.60 | $6.84 | +15.64% |
| Q4 2015 | 2015-12-31 | $48.82 | $15.48 | +46.42% |
| Q3 2015 | 2015-09-30 | $47.50 | $14.87 | +45.55% |
| Q2 2015 | 2015-06-30 | $47.28 | $16.00 | +51.12% |
| Q1 2015 | 2015-03-31 | $43.76 | $14.26 | +48.35% |
| Q4 2014 | 2014-12-31 | $33.34 | $4.27 | +14.69% |
| Q3 2014 | 2014-09-30 | $32.64 | $3.42 | +11.69% |
| Q2 2014 | 2014-06-30 | $31.29 | $1.86 | +6.32% |
| Q1 2014 | 2014-03-31 | $29.50 | -$0.44 | −1.48% |
| Q4 2013 | 2013-12-31 | $29.07 | -$23.82 | −45.04% |
| Q3 2013 | 2013-09-30 | $29.22 | $0.59 | +2.07% |
| Q2 2013 | 2013-06-30 | $29.43 | $1.96 | +7.13% |
| Q1 2013 | 2013-03-31 | $29.94 | $3.19 | +11.91% |
| Q4 2012 | 2012-12-31 | $52.89 | $27.29 | +106.61% |
| Q3 2012 | 2012-09-30 | $28.63 | $3.12 | +12.22% |
| Q2 2012 | 2012-06-30 | $27.47 | $2.03 | +7.98% |
| Q1 2012 | 2012-03-31 | $26.75 | $2.80 | +11.67% |
| Q4 2011 | 2011-12-31 | $25.60 | $1.51 | +6.28% |
| Q3 2011 | 2011-09-30 | $25.51 | $3.19 | +14.28% |
| Q2 2011 | 2011-06-30 | $25.44 | $4.02 | +18.74% |
| Q1 2011 | 2011-03-31 | $23.96 | $3.24 | +15.65% |
| Q4 2010 | 2010-12-31 | $24.08 | $4.08 | +20.42% |
| Q3 2010 | 2010-09-30 | $22.32 | $3.27 | +17.18% |
| Q2 2010 | 2010-06-30 | $21.43 | $2.96 | +16.02% |
| Q1 2010 | 2010-03-31 | $20.71 | — | — |
| Q4 2009 | 2009-12-31 | $20.00 | $4.40 | +28.18% |
| Q3 2009 | 2009-09-30 | $19.05 | — | — |
| Q2 2009 | 2009-06-30 | $18.47 | — | — |
| Q4 2008 | 2008-12-31 | $15.60 | — | — |
Labcorp Holdings book value per share trends
Over the last five fiscal years, Labcorp Holdings's book value per share increased from $96.79 to $104.86, a change of $8.08. The latest reported quarter, Q2 2026, shows $106.39.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...